Satyajeet P, Kalyanram K, Deepak D, Vasudevan T, Joseph Philipraj, Mossadeq A
#Cap stable pvp prodeus 2017 serial#
Although the exposure levels are within safety limits, serial monitoring and constant vigilance are mandatory to sensitize surgeons. Increasing size and low HU of stone, increasing number of tracts, fluoroscopic access to PCS, increasing sheath size and kV are found to increase radiation exposure.
BMI, number of stones, degree of hydronephrosis, operative time and placement of DJ /ureteric catheter/PCN did not have any correlation with REĬONCLUSION: Mean RE per procedure was 0.21☐.11mSv. The HU had negative relation with decrease in HU causing increased RE (β= -0.137,p=0.002). The parameters analyzed were age, number and size of stones, BMI of patients, Hounsfield unit of stone (HU), degree of hydronephrosis, number of tracts, mode of access to PCS, sheath size (Fr), operative time (minutes), placement of DJ/ureteric catheter/PCN and kV used for exposure. RESULTS: We utilized Multivariate regression analysis to identify various parameters which affect RE (mSv). RE was determined using pen dosimeter worn outside lead apron of surgeon. Surgico 60DHF™, digitalised mobile surgical Carm image intensifier system was used in all cases. Informed consent was obtained from enrolled patients. METHODS: Total of 212 patients who underwent PCNL during study period were analyzed. The objective of this study is to measure and analyze various factors affecting RE to surgeons during PCNL. INTRODUCTION AND OBJECTIVES: PercutaneousNephrolithotomy (PCNL) is single most common procedure performed for large stone burden and is associated with potential Radiation Exposure (RE). Muljibhai Patel Urological Hospital, Nadiad Sudharsan SB, Mohankumar V, Singh A, Ganpule A, Sabnis R, Desai M The exact mechanism of these findings needs further clinical and experimental research.
Loss of seminal ejaculation with silodosin appears the cause of seminal vesicle enlargement. All three groups demonstrated statistically significant enlargement of seminal vesicles after 12 weeks’ treatment, but in absolute value, seminal vesicle volume in group A patients becomes almost double of baseline volume (7.65 to 14.11 cc, p=0.0001).Ĭonclusion-Alpha blockers as silodosin, tamsulosin and alfuzosin are a safe and effective tool in BPH for improving LUTS and quality of life. At 12 weeks of treatment, silodosin, tamsulosin and alfuzosin had significant improvement in total IPSS and QOL score (p=0.0001). Results- The mean age of our study population was 54.8 + 4.9 years (41- 68 years). Patients were divided into group A, group B and group C based on the prescription of silodosin 8 mg, tamsulosin 0.4 mg or alfuzosin 10 mg orally once for LUTS and evaluated 4 weeks and 12 weeks. We excluded patients with a history of prostate surgery, suspicious digital rectal examination findings, serum PSA level >4 ng/dl, history of medication with anticholinergic/cholinergic /diuretic agents. We enrolled sexually active men above the age of 40 years having moderate to severe lower urinary tract symptoms. Methods- A prospective cohort study from January 2015 to December 2016. We also evaluated seminal vesicle enlargement and its possible clinical application. Introduction and objective- To evaluate sexual dysfunction and change in volume of seminal vesicles in sexually active male who were treated by alpha blockers for BPH. King George's Medical University, Lucknow
Sokhal AK, Sankhwar SN, Goel A, Singh B P, Kumar M, Saini D, Purkait B
0 kommentar(er)
